LT - Kombinuota terapija, apimanti P13K-alfa chinoksalino inhibitorių, skirta naudoti vėžio gydymui
EN - COMBINATION THERAPIES COMPRISING A QUINOXALINE INHIBITOR OF PI3K-ALPHA FOR USE IN THE TREATMENT OF CANCER
Legal status
Patent lapsed (non-payment of fees)
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/497 |
(2006.01) |
|
|
A61K 31/498 |
(2006.01) |
|
|
A61K 31/4985 |
(2006.01) |
|
|
A61K 31/517 |
(2006.01) |
|
|
A61K 31/436 |
(2006.01) |
|
|
A61K 31/555 |
(2006.01) |
|
|
A61K 31/337 |
(2006.01) |
|
|
A61K 45/06 |
(2006.01) |
|
|
A61P 35/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
2139483 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
08742674.8 |
|
Date of filing the European patent application |
2008-04-08 |
| (97) |
Date of publication of the European application |
2010-01-06 |
| (45) |
Date of publication and mention of the grant of the patent |
2013-09-18
|
| (46) |
Date of publication of the claims translation |
2013-11-25
|
PCT application
| (86) |
Number |
PCT/US2008/004570 |
|
Date |
2008-04-08 |
PCT application publication
| (87) |
Number |
WO 2008/127594 |
|
Date |
2008-10-23 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
923164 P |
2007-04-11
|
US |
Inventors
| (72) |
LAMB, Peter, US
MATTHEWS, David, US
|
Grantee
| (73) |
Exelixis, Inc.,
210 East Grand Avenue, South San Francisco, CA 94080,
US
|
Attorney or representative
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
Title
| (54) |
Kombinuota terapija, apimanti P13K-alfa chinoksalino inhibitorių, skirta naudoti vėžio gydymui |
| |
COMBINATION THERAPIES COMPRISING A QUINOXALINE INHIBITOR OF PI3K-ALPHA FOR USE IN THE TREATMENT OF CANCER |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2020-04-03 |
13 |
289.00
EUR
|
Legal status
|
Patent lapsed (non-payment of fees)
|
|
|
Invalidation date |
2021-04-08 |
